Use of immunomodulatory therapies in post-surgical patients in intensive care: Benefits and risks
DOI:
https://doi.org/10.33448/rsd-v13i8.46549Keywords:
Immunomodulators; Recovery; Intensive Care Units; Postoperative complications.Abstract
The management of post-surgical patients in ICUs is challenging due to the severity of the conditions and the need for advanced interventions. Immunomodulatory therapies have been studied as a promising strategy to improve clinical outcomes by regulating the immune response and reducing complications after surgery. Objective and Methodology: The objective of this article is to present an integrative bibliographic research study of immunomodulatory therapies in post-surgical patients in Intensive Care. Results and Discussions: The variety of applications of immunomodulators, including treatments for critical conditions such as Stevens-Johnson Syndrome, sepsis and Systemic Inflammatory Response Syndrome (SIRS). Significant advances have been observed in biologics, immunotherapy, cellular therapies, and immunonutrients, with documented safety and efficacy profiles. Treated patients had a lower incidence of nosocomial infections and a reduction in inflammatory markers, such as CRP and IL-6, contributing to clinical improvements in the ICU. Conclusion: Highlights the benefits of immunomodulatory therapies in reducing complications and controlling inflammatory responses, although it warns about associated risks, such as inadequate immune suppression. More research is needed to integrate these therapies into standard clinical protocols, ensuring maximum effectiveness and full understanding of the benefits and risks involved.
References
Amodeo, G., Bugada, D., Franchi, S., Moschetti, G., Grimaldi, S., Panerai, A., et al. (2018, julho). Immune function after major surgical interventions: the effect of postoperative pain treatment. Journal of Pain Research, 11, 1297-1305.
Azevedo, Franco, E. S., Costa, S. A., Silva, L. M. M., et al. (2023). Elaboração do protocolo de terapia nutricional de imunomoduladores para pacientes pré-cirúrgicos. Revista Ibero-Americana de Humanidades, Ciências e Educação, 9(9), 2981-3000.
Bittencourt, E. da S., Moreira, P. S., Paixão, G. M. da, & Cardoso, M. M. (2021). A atuação do terapeuta ocupacional em Unidade de Terapia Intensiva: uma revisão sistemática. Cadernos Brasileiros de Terapia Ocupacional, 29.
Campos, S. S., Cintra, B. B., & Ximenes, R. M. V. (2023, outubro 28). Intervenções terapêuticas para o tratamento sistêmico da Síndrome de Stevens-Johnson (SSJ) e Necrólise Epidérmica Tóxica (NET): Uma revisão integrativa. Research, Society and Development, 12(11), e71121143488.
Gómez Candela, C., Palma Milla, S., Carrillo Lozano, E., Di Martino, M., González Alcolea, N., Olivar Roldán, J., et al. (2021). Immunonutrition in fast-track surgical patients — evidence review and adapted algorithm. Nutrición Hospitalaria.
Carmo, S. G. do, & Fortes, R. C. (2019). Efeitos do uso de fórmulas imunomoduladoras em pacientes cirúrgicos portadores de câncer do trato gastrointestinal. REVISA (Online), 96-111.
Carvalho Novaes, C., Barros Costa, M., Duanne, S., Castro, A., Romualdo, F., Neto, S., Alves De Macêdo, M., Virgínia, H., Santos, D., Silva De Araújo, I., Ferreira Da, R., Nascimento, S., & Araujo De Miranda, M. (n.d.). A importancia da utilização de imunomoduladores no pré e pós-operatório - uma revisão integrativa. https://eventos.univasf.edu.br/index.php/nutriebserh/IForNutri/paper/downloadSuppFile/974/264
Choi, Y., Debbaneh, M., Weinberg, J., Yamauchi, P., Voorhees, A., Armstrong, A., Siegel, M., & Wu, J. (2016). From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis. Journal of the American Academy of Dermatology, 75(4), 798-805.e7.
Damasceno, N. R. T., Gowdak, M., Passos, A., de Oliveira, L., & Borba, L. (2018). Emergências cardiológicas, suplementos nutricionais e imunomoduladores - parte 2. Revista da Sociedade de Cardiologia do Estado de São Paulo, 28(4), 479-485.
Dantas, M., Freire, M., Graciele, E., Neves, A., Menezes Freire, S., Ney, A., et al. (2024). O uso da glutamina em cirurgia: Atualização em Cirurgia Geral. Revista Científica do Hospital Santa Izabel.
Jain, A., Singam, A., & Mudiganti, V. S. (2024). Recent advances in immunomodulatory therapy in sepsis: A comprehensive review. Cureus, 16(3), e57309.
Lima, H. C. (2007). Fatos e mitos sobre imunomoduladores. Anais Brasileiros de Dermatologia, 82(3), 207–221.
Mahmud, F., Roy, R., Mohamed, M. F., Aboonabi, A., Moric, M., Ghoreishi, K., et al. (2021). Therapeutic evaluation of immunomodulators in reducing surgical wound infection. The FASEB Journal, 36(1).
Malekahmadi, M., Pahlavani, N., Firouzi, S., Clayton, Z. S., Islam, S. M. S., Rezaei Zonooz, S., et al. (2022). Effect of enteral immunomodulatory nutrition formula on mortality and critical care parameters in critically ill patients: A systematic review with meta-analysis. Nursing in Critical Care, 27(6), 838-848.
Marik, P., & Zaloga, G. (2010). Immunonutrition in high-risk surgical patients: a systematic review and analysis of the literature. JPEN. Journal of Parenteral and Enteral Nutrition, 34(4), 378-386.
Olson, C. P., Kennedy, M. I., DePhillipo, N. N., Tagliero, A. J., LaPrade, R. F., & Kennedy, N. I. (2024). Effect of anti-inflammatory treatments on patient outcomes and concentrations of inflammatory modulators in the post-surgical and post-traumatic tibiofemoral joint setting: a narrative review. Annals of Joint, 9.
Snyder, H. (2019). Literature review as a research methodology. Journal of Business Research, 104, 333-339.
Sousa, F. das C. A., Silva, M. F. da, Silva, W. C. da, Andrade, E. W. O. F., Silva, F. D. R. da, Santos, M. J. dos, et al. (2020 1). Imunonutrição em pacientes oncológicos: revisão integrativa. Research, Society and Development, 9(2), e100922004.
Souza, Y. D. do E. S., Moreira, J. S. B., Lobato, T. A. A., Costa, R. L. V., & Teixeira, L. M. de A. (2023). Impacto do uso de imunonutrientes no desfecho clínico de pacientes críticos: uma revisão sistemática de estudos clínicos. Demetra (Rio J).
Teh, B., Harrison, S., Worth, L., Thursky, K., & Slavin, M. (2016). Infection risk with immunomodulatory and proteasome inhibitor-based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysis. European Journal of Cancer, 67, 21-37.
Tiberi, S., Torrico, M. M., Rahman, A., Krutikov, M., Visca, D., Silva, D. R., et al. (2019). Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation. Jornal Brasileiro de Pneumologia, 45(2), e20180324.
Uchida, K. (2019). Post-surgical immune suppression: another target to improve postoperative outcomes. Journal of Anesthesia, 33(6), 625-627.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Alessandra Machado Cordella; Willas Ferreira Furtado; Clarice Terranova Agostinho; João Thales Vasconcelos Martins; Maximiano Avelar Rodrigues; Kassio Viana Pereira; Víctor Ferreira; Ana Vitória Ramos Menezes; Antonia Rafaelly Fernandes Silva; Nijair Araújo Pinto
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.